Search

Your search keyword '"Weghuber, Daniel"' showing total 582 results

Search Constraints

Start Over You searched for: Author "Weghuber, Daniel" Remove constraint Author: "Weghuber, Daniel"
582 results on '"Weghuber, Daniel"'

Search Results

2. Übergewicht und Adipositas bei Erwachsenen: allgemeine Behandlungsgrundsätze und konservatives Management

3. General and abdominal adiposity and hypertension in eight world regions: a pooled analysis of 837 population-based studies with 7·5 million participants

5. Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults

6. Genotypic and phenotypic spectrum of infantile liver failure due to pathogenic TRMU variants

8. Association between alanine aminotransferase as surrogate of fatty liver disease and physical activity and sedentary time in adolescents with obesity

9. Poorly controlled pediatric type 1 diabetes mellitus is a risk factor for metabolic dysfunction associated steatotic liver disease (MASLD): An observational study

10. Nationales Konzept zur Therapie von Übergewicht und Adipositas im Kindes- und Jugendalter der Österreichischen Gesellschaft für Kinder- und Jugendheilkunde und beteiligter medizinisch-wissenschaftlicher Fachgesellschaften, Fachverbände und weiterer Organisationen*: Version 6. Dezember 2021

11. Fully Convolutional Networks for Automated Segmentation of Abdominal Adipose Tissue Depots in Multicenter Water-Fat MRI

13. Studies in children with obesity in two European treatment centres show a high prevalence of impaired glucose metabolism in the Swedish cohort

14. Rise in fasting and dynamic glucagon levels in children and adolescents with obesity is moderate in subjects with impaired fasting glucose but accentuated in subjects with impaired glucose tolerance or type 2 diabetes.

21. Pharmacological interventions for the management of children and adolescents living with obesity—An update of a Cochrane systematic review with meta‐analyses.

23. Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control

31. Lifestyle interventions to change trajectories of obesity-related cardiovascular risk from childhood onset to manifestation in adulthood: a joint scientific statement of the task force for childhood health of the European Association of Preventive Cardiology and the European Childhood Obesity Group

34. Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control

35. Alternativen zu Säuglingsnahrungen auf Kuhmilchproteinbasis

36. Metabolomic profiling identifies potential pathways involved in the interaction of iron homeostasis with glucose metabolism

37. Screening for Inflammatory Markers Identifies IL-18Rα as a Potential Link between Exenatide and Its Anti-Inflammatory Effect: New Results from the Combat-JUDO Randomized Controlled Trial.

40. The association between perinatal factors and cardiometabolic risk factors in children and adolescents with overweight or obesity: A retrospective two-cohort study

41. Single Point Insulin Sensitivity Estimator (SPISE) As a Prognostic Marker for Emerging Dysglycemia in Children with Overweight or Obesity

42. The relationship between glucose and the liver-alpha cell axis – A systematic review

43. After 32 Years of Action and Engagement, the European Childhood Obesity Group Keeps Fighting for the Best Prevention and Treatment of Pediatric Obesity

44. Diminishing benefits of urban living for children and adolescents’ growth and development

46. Who benefits most from outpatient lifestyle intervention? An IMI‐SOPHIA study on pediatric individuals living with overweight and obesity.

47. Alternativen zu Säuglingsnahrungen auf Kuhmilchproteinbasis: Stellungnahme der Ernährungskommission der Österreichischen Gesellschaft für Kinder und Jugendheilkunde (ÖGKJ), der Ernährungskommission der Deutschen Gesellschaft für Kinder- und Jugendmedizin (DGKJ) und der Ernährungskommission der Schweizerischen Gesellschaft für Pädiatrie (SGP)

48. Once-Weekly Semaglutide in Adolescents with Obesity

49. Clinical characteristics and cardiovascular risk profile in children and adolescents with latent autoimmune diabetes: Results from the German/Austrian prospective diabetes follow‐up registry

Catalog

Books, media, physical & digital resources